Search results for "Type 2"

showing 10 items of 1034 documents

Effectiveness of different vaccine formulations against vibriosis caused by Vibrio vulnificus serovar E (biotype 2) in European eels Anguilla anguilla

2001

Vibriosis due to Vibrio vulnificus serovar E (biotype 2) is one of the main causes of mortality in European eels cultured in Europe. The main objective of this study was to develop a vaccine and a vaccination procedure against this pathogen. With this aim, we tested several vaccine formulations (inactivated whole-cells with and without toxoids‹inactivated extracellular products‹from capsulated and uncapsulated strains, attenuated live vaccines and purified lipopolysaccharide [LPS]) on eels maintained under controlled laboratory conditions using different delivery routes (injection and immersion). To study the immune response we estimated antibody titers and bactericidal/bacteriostatic activ…

SerotypeQuality ControlVibrio vulnificus serovar E ; Vibrio vulnificus biotype 2 ; Eel vaccines ; Vibrio vaccines ; Vaccination by injection ; Vaccination by prolonged immersionImmunization SecondaryVibrio vulnificus biotype 2Eel vaccinesVibrio vulnificusAquacultureAquatic ScienceBiologyAntibodies Viral:CIENCIAS DE LA VIDA [UNESCO]MicrobiologyFish DiseasesVaccination by injectionAntigenVibrionaceaeImmunityAntibody SpecificityUNESCO::CIENCIAS DE LA VIDAAnimalsUNESCO::CIENCIAS DE LA VIDA::Biología animal (Zoología)Vibrio vaccinesPathogenEcology Evolution Behavior and SystematicsVaccination by prolonged immersionSkinVibrio:CIENCIAS DE LA VIDA::Biología animal (Zoología) [UNESCO]VaccinationAntibody titerbiology.organism_classificationAnguillaVirologyVaccinationEuropeVibrio vulnificus serovar EVibrio InfectionsBacterial Vaccines
researchProduct

Field testing of a vaccine against eel diseases caused by Vibrio vulnificus

2001

The field results of a vaccination programme against Vibrio vulnificus serovar E (biotype 2) in a Spanish eel farm are reported. A total of 9.5 million glass eels were vaccinated from January 1998 to March 2000 by prolonged immersion followed by 2 subsequent reimmunisations after 12 to 14 and 24 to 28 d, respectively. The acquired protection and the immune response against serovar E were estimated over a period of 6 mo after vaccination. A similar vaccination schedule was conducted with elvers in a Danish eel farm. In this case, the acquired protection and the immune response against serovar E and the new eel-pathogenic serovars, recently described in Denmark, were evaluated over a short te…

Serotypeendocrine systemTime Factorsanimal structuresVaccination scheduleField vaccination. vibriosisVibrio vulnificus biotype 2Eel vaccinesVibrio vulnificusAquatic Science:CIENCIAS DE LA VIDA [UNESCO]MicrobiologyFish DiseasesImmune systemVibrionaceaeAnguillidaeUNESCO::CIENCIAS DE LA VIDAAnimalsUNESCO::CIENCIAS DE LA VIDA::Biología animal (Zoología)Vibrio vaccinesEcology Evolution Behavior and SystematicsVaccination by prolonged immersionVibrioEels:CIENCIAS DE LA VIDA::Biología animal (Zoología) [UNESCO]biologyVibrio vulnificus serovar E ; Vibrio vulnificus biotype 2 ; Eel vaccines ; Vibrio vaccines ; Vaccination by prolonged immersion ; Field vaccination. vibriosisBody WeightVaccinationbiology.organism_classificationAntibodies BacterialVaccinationVibrio vulnificus serovar EVibrio InfectionsHumoral immunityBacterial Vaccines
researchProduct

Vitamin D Deficiency in HIV Infection: Not Only a Bone Disorder

2015

Hypovitaminosis D is a worldwide disorder, with a high prevalence in the general population of both Western and developing countries. In HIV patients, several studies have linked vitamin D status with bone disease, neurocognitive impairment, depression, cardiovascular disease, high blood pressure, metabolic syndrome, type 2 diabetes mellitus, infections, autoimmune diseases like type 1 diabetes mellitus, and cancer. In this review, we focus on the most recent epidemiological and experimental data dealing with the relationship between vitamin D deficiency and HIV infection. We analysed the extent of the problem, pathogenic mechanisms, clinical implications, and potential benefits of vitamin …

Settore MED/09 - Medicina InternaBone diseasePopulationlcsh:MedicineHIV InfectionsReview ArticleDiseaseGeneral Biochemistry Genetics and Molecular Biologyvitamin D deficiencyRisk FactorsAntiretroviral Therapy Highly ActivePrevalenceVitamin D and neurologyHumansMedicineHIV InfectionAntiretroviral Therapy Highly Active; HIV Infections; Humans; Prevalence; Risk Factors; Vitamin D Deficiency; Bone Diseases; Biochemistry Genetics and Molecular Biology (all); Immunology and Microbiology (all)educationeducation.field_of_studyType 1 diabetesGeneral Immunology and Microbiologybusiness.industryRisk Factorlcsh:RType 2 Diabetes MellitusVitamin D Deficiency; HIV Infection; Bone DisorderGeneral MedicineVitamin D Deficiencymedicine.diseaseImmunologyBone DiseasesMetabolic syndromebusinessHumanBioMed Research International
researchProduct

Consensus On Women'S Health Aspects Of Polycystic Ovary Syndrome (Pcos)

2012

Polycystic ovary syndrome (PCOS) is the most common endocrine disorder in females with a high prevalence. The etiology of this heterogeneous condition remains obscure and its phenotype expression varies. Two, widely cited, previous ESHRE/ASRM-sponsored PCOS consensus workshops focused on diagnosis (published in 2004) and infertility management (published in 2008). The present third PCOS consensus paper summarizes current knowledge and identifies knowledge gaps regarding various women's health aspects of PCOS. Relevant topics addressed-all dealt with in a systematic fashion-include adolescence, hirsutism and acne, contraception, menstrual cycle abnormalities, quality of life, ethnicity, preg…

Settore MED/09 - Medicina InternaConsensus Development Conferences as TopicmenopauseType 2 diabetesSettore MED/13 - EndocrinologiaQuality of lifecancer; cardiovascular disease; contraception; hirsutism; insulin resistance; menopause; PCOS; pregnancy; quality of life; type 2 diabetescardiovascular diseaseNeoplasmsinsulin resistancePCOShirsutismhirsutismReproductive BiologyPolycystic ovary syndrome (PCOS)RehabilitationObstetrics and GynecologyObstetrics & GynecologyMiddle AgedMenopausePhenotypecontraceptionCardiovascular DiseasesPCOS Cardiovascular risk adolescence cancer obesityFemalepregnancytype 2 diabetesPolycystic Ovary SyndromeAdultmedicine.medical_specialtyConsensusAdolescentDiabetes ComplicationsInsulin resistanceSDG 3 - Good Health and Well-beingmedicineHumanscancerMenstrual CycleAgedGynecologyPregnancybusiness.industryCancermedicine.diseaseSettore MED/40 - Ginecologia E OstetriciaReproductive MedicineDiabetes Mellitus Type 2quality of lifeWomen's Healthbusiness
researchProduct

Techniques to evaluate erythrocyte deformability in diabetes mellitus

2005

Using several rheological techniques, we examined the erythrocyte deformability in different groups of diabetic subjects. The macrorheological techniques used for this evaluation were respectively whole-blood filtration, filtration of erythrocyte suspensions, polyviscosimetry and diffractometry. Whole-blood filterability, at a negative pressure of 20 cm water, was decreased in type 2 diabetics; no difference was evident at a negative pressure of 10 cm water. The filtration of erythrocyte suspensions at low haematocrit (5%) did not show differences between normal and diabetic subjects. The polyviscosimetry, which explores the filterability of erythrocyte suspensions at high haematocrit (80%)…

Settore MED/09 - Medicina InternaEndocrinology Diabetes and MetabolismHematocritFluorescence spectroscopypolyviscosimetrylaw.inventionEndocrinologyReference ValueslawErythrocyte DeformabilityDiabetes mellitusDiabetes MellitusInternal MedicinemedicineHumansErythrocyte deformabilityLaser beamsFiltrationwhole-blood filtrationmedicine.diagnostic_testdiabetes mellituViscosityChemistryErythrocyte MembraneGeneral Medicinemedicine.diseaseRed cell membraneDiabetes Mellitus Type 1MembraneDiabetes Mellitus Type 2HematocritBiochemistryerythrocyte filtrationBiophysicsdiffractometryerythrocyte membrane dynamic propertieActa Diabetologica
researchProduct

TYPE 2 DIABETES AND ALZHEIMER’S DISEASE

2014

Epidemiological and biological evidences support a link between type 2 diabetes mellitus (DM2) and Al-zheimer’s disease (AD). Persons with diabetes have a higher incidence of cognitive decline and an increased risk of developing all types of dementia. Cognitive deficits in persons with diabetes mainly affect the ar-eas of psychomotor efficiency, attention, learning and memory, mental flexibility and speed, and executive function. The strong epidemiological association has suggested the existence of a physiopathological link. The determinants of the accelerated cognitive decline in DM2, however, are less clear. Increased cortical and subcortical atrophy have been evidenced after con-trolling…

Settore MED/09 - Medicina InternaHyperglycemiaAlzheimerAg-ingCognitive declineMild cognitive impairmentDementiaInsu-linType 2 diabeteHypoglycemia
researchProduct

MAGNESIUM METABOLISM IN TYPE 2 DIABETES MELLITUS

2011

Settore MED/09 - Medicina InternaMagnesium Type 2 diabetes mellitus Hypertension Ionized magnesium Insulin resistance
researchProduct

Identifying predictors of response to liraglutide in type 2 diabetes using recursive partitioning analysis

2014

Settore MED/09 - Medicina Internatype 2 diabetes liraglutide efficacySettore MED/49 - Scienze Tecniche Dietetiche ApplicateSettore MED/13 - Endocrinologia
researchProduct

Alogliptin after acute coronary syndrome in patients with type 2 diabetes

2013

BACKGROUND: To assess potentially elevated cardiovascular risk related to new antihyperglycemic drugs in patients with type 2 diabetes, regulatory agencies require a comprehensive evaluation of the cardiovascular safety profile of new antidiabetic therapies. We assessed cardiovascular outcomes with alogliptin, a new inhibitor of dipeptidyl peptidase 4 (DPP-4), as compared with placebo in patients with type 2 diabetes who had had a recent acute coronary syndrome. METHODS: We randomly assigned patients with type 2 diabetes and either an acute myocardial infarction or unstable angina requiring hospitalization within the previous 15 to 90 days to receive alogliptin or placebo in addition to exi…

Settore MED/11 - Malattie Dell'Apparato CardiovascolareAlogliptin acute coronary syndrome type 2 diabetes
researchProduct

The complex interplay between vitamin D deficiency and diabetes

2015

It has been recently highlighted the link between vitamin D and metabolic and immunological pro- cesses, which established its role as an essential component of human health preservation. Vitamin D has been defined as natural immune modulators, and through the activation of its receptors (VDRs), it regulates calcium metabolism, cellular growth, proliferation and apoptosis, and other immunological functions. In this setting, vita- min D has also been reported to influence glucose regulation via effects on insulin secretion and action. Vitamin D deficiency is strongly associated with obesity mostly due to the storage of vitamin D in adipose tissue because of its lipophilic properties. The dec…

Settore MED/12 - GastroenterologiaTYPE 1 DIABETES TYPE 2 DIABETES VITAMIN D
researchProduct